In the brain, PCSK9 binds to LRP1 and impedes β-amyloid protein clearance, and interacts with various inflammatory factors, underpinning neurodegenerative conditions like Alzheimer’s disease (AD) (Mazura et al., 2022). Here, LRP1 is linked to Alzheimer disease.